Liver Diseases
Welcome,         Profile    Billing    Logout  
 307 Companies   474 Products   474 Products   223 Mechanisms of Action   25 Trials   4911 News 


«12...1516171819202122232425...9899»
  • ||||||||||  Hepatoren (ifetroban) / Cumberland
    Trial completion, Trial primary completion date:  Safety and Pharmacokinetics of Ifetroban in Hepatorenal Syndrome Patients (clinicaltrials.gov) -  Dec 5, 2015   
    P2,  N=55, Completed, 
    N=24 --> 36 | Trial primary completion date: Dec 2015 --> Jun 2016 Recruiting --> Completed | Trial primary completion date: Dec 2015 --> Jun 2015
  • ||||||||||  Trial completion, Trial primary completion date:  DietLFAT: Effect of Diet Composition on Liver Fat and Glucose Metabolism (clinicaltrials.gov) -  Dec 5, 2015   
    P=N/A,  N=16, Completed, 
    Active, not recruiting --> Completed Active, not recruiting --> Completed | Trial primary completion date: Jun 2014 --> Sep 2012
  • ||||||||||  ceftriaxone / Generic mfg., moxifloxacin intravenous / Generic mfg.
    Trial completion, Enrollment change, Trial primary completion date:  Moxifloxacin Versus Ceftriaxone in the Treatment of Primary Pyogenic Liver Abscess (clinicaltrials.gov) -  Dec 5, 2015   
    P4,  N=24, Completed, 
    Active, not recruiting --> Completed | Trial primary completion date: Jun 2014 --> Sep 2012 Recruiting --> Completed | N=48 --> 24 | Trial primary completion date: Apr 2012 --> Dec 2010
  • ||||||||||  Enrollment change, Trial withdrawal, Trial primary completion date:  INHEPP;UTINH: Effect of Isoniazid on Protoporphyrin Levels in Erythropoietic Protoporphyria (clinicaltrials.gov) -  Dec 5, 2015   
    P=N/A,  N=0, Withdrawn, 
    Recruiting --> Completed | N=48 --> 24 | Trial primary completion date: Apr 2012 --> Dec 2010 N=24 --> 0 | Enrolling by invitation --> Withdrawn | Trial primary completion date: Feb 2014 --> Dec 2015
  • ||||||||||  emtricitabine/tenofovir disoproxil fumarate / Generic mfg., lopinavir/ritonavir / Generic mfg.
    Trial completion, Enrollment change:  Highly Active Antiretroviral Therapy for Patients With Primary Biliary Cirrhosis (clinicaltrials.gov) -  Dec 5, 2015   
    P=N/A,  N=13, Completed, 
    Active, not recruiting --> Completed Active, not recruiting --> Completed | N=80 --> 13
  • ||||||||||  5-fluorouracil / Generic mfg., mitomycin / Generic mfg., sorafenib / Generic mfg.
    Enrollment change, Trial initiation date, Trial withdrawal, Trial primary completion date:  The Efficacy of 5-fluorouracil/Mitomycin for the Patients With Pulmonary Metastasis of Hepatocellular Carcinoma (clinicaltrials.gov) -  Dec 4, 2015   
    P2,  N=0, Withdrawn, 
    Trial primary completion date: Sep 2015 --> Sep 2016 N=40 --> 0 | Initiation date: Sep 2013 --> Nov 2015 | Recruiting --> Withdrawn | Trial primary completion date: Aug 2015 --> Nov 2015
  • ||||||||||  Trial primary completion date:  Prognosis Factors of Cardiac Complications After Liver Transplantation (clinicaltrials.gov) -  Dec 4, 2015   
    P=N/A,  N=500, Recruiting, 
    Active, not recruiting --> Completed | Trial primary completion date: Sep 2016 --> Oct 2015 Trial primary completion date: Jan 2018 --> Jan 2017
  • ||||||||||  MG4101 / GC Pharma
    Trial completion, Preclinical, Enrollment change, Trial primary completion date:  to Evaluate the Efficacy and Safety of MG4101(Ex Vivo Expanded Allogeneic NK Cell) (clinicaltrials.gov) -  Dec 4, 2015   
    P2,  N=5, Completed, 
    Trial primary completion date: May 2015 --> May 2016 Recruiting --> Completed | N=20 --> 5 | Trial primary completion date: Aug 2016 --> Oct 2015
  • ||||||||||  Engerix-B (hepatitis B vaccine recombinant) / GSK
    Trial primary completion date:  Hepatitis B Booster Study in Adolescence (clinicaltrials.gov) -  Dec 4, 2015   
    P=N/A,  N=360, Active, not recruiting, 
    Recruiting --> Completed | N=20 --> 5 | Trial primary completion date: Aug 2016 --> Oct 2015 Trial primary completion date: Aug 2015 --> Nov 2015
  • ||||||||||  Peyona (caffeine citrate) / Chiesi
    Trial initiation date, Trial primary completion date:  NOCTUA: Inhibition of VAP-1 by Caffeine in Healthy Human Volunteers Study (clinicaltrials.gov) -  Dec 4, 2015   
    P1,  N=63, Not yet recruiting, 
    Enrolling by invitation --> Active, not recruiting Initiation date: Jul 2015 --> Mar 2016 | Trial primary completion date: Sep 2015 --> Sep 2016
  • ||||||||||  Trial termination, MRI:  T2 Weighted Imaging of the Liver With Fast Spin Echo MRI (clinicaltrials.gov) -  Nov 19, 2015   
    P=N/A,  N=50, Terminated, 
    Recruiting --> Active, not recruiting Recruiting --> Terminated; Trial Logistics
  • ||||||||||  sorafenib / Generic mfg.
    Enrollment closed, Trial primary completion date, Metastases:  Ph 1 Trial of ADI PEG 20 Plus Sorafenib to Treat Patients With Liver Cancer (clinicaltrials.gov) -  Nov 19, 2015   
    P1,  N=21, Active, not recruiting, 
    N=180 --> 0 | Not yet recruiting --> Withdrawn Recruiting --> Active, not recruiting | Trial primary completion date: May 2016 --> Feb 2016